| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 70.44B | 70.01B | 67.73B | 56.79B | 49.98B | 44.06B |
| Gross Profit | 18.51B | 18.12B | 16.50B | 13.56B | 11.99B | 11.16B |
| EBITDA | 7.19B | 6.61B | 6.53B | 5.33B | 4.28B | 3.96B |
| Net Income | 3.32B | 2.81B | 3.60B | 2.48B | 1.52B | 2.38B |
Balance Sheet | ||||||
| Total Assets | 69.41B | 71.71B | 70.10B | 61.00B | 55.05B | 54.00B |
| Cash, Cash Equivalents and Short-Term Investments | 21.20B | 21.90B | 18.94B | 18.02B | 14.77B | 14.25B |
| Total Debt | 5.15B | 5.31B | 5.75B | 5.53B | 5.15B | 4.94B |
| Total Liabilities | 21.05B | 23.23B | 25.76B | 21.95B | 19.50B | 19.31B |
| Stockholders Equity | 45.44B | 45.51B | 41.56B | 36.65B | 33.39B | 31.97B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 3.92B | 4.02B | 3.11B | 1.00B | 3.38B |
| Operating Cash Flow | 0.00 | 5.71B | 5.33B | 4.17B | 2.10B | 4.32B |
| Investing Cash Flow | 0.00 | -1.38B | -3.90B | -2.51B | -1.46B | -1.81B |
| Financing Cash Flow | 0.00 | -1.45B | -1.70B | -482.00M | -1.69B | -574.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥40.97B | 8.57 | ― | 1.78% | -0.94% | 51.59% | |
79 Outperform | ¥91.03B | 14.20 | ― | 3.38% | 10.74% | -26.50% | |
73 Outperform | ¥54.03B | 13.47 | ― | 3.00% | 16.06% | 31.78% | |
67 Neutral | ¥160.90B | 6.77 | ― | 1.72% | 32.43% | 39.26% | |
64 Neutral | ¥71.23B | 15.26 | ― | 3.17% | 5.95% | 23.97% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
61 Neutral | ¥151.54B | 9.23 | ― | 2.42% | 9.74% | 6.48% |